Vaccinia virus A28L gene encodes an essential protein component of the virion membrane with intramolecular disulfide bonds formed by the viral cytoplasmic redox pathway.
about
Host-derived pathogenicity islands in poxvirusesPoxvirus cell entry: how many proteins does it take?Drosophila S2 cells are non-permissive for vaccinia virus DNA replication following entry via low pH-dependent endocytosis and early transcriptionA novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis.Salmon Gill Poxvirus, the Deepest Representative of the Chordopoxvirinae.Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid raftsVaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusionVaccinia virus A21 virion membrane protein is required for cell entry and fusionThe product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion.The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell componentsThe conserved poxvirus L3 virion protein is required for transcription of vaccinia virus early genes.Poxvirus multiprotein entry-fusion complexEntry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene.Inducible gene expression in tumors colonized by modified oncolytic vaccinia virus strainsVaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles.Interaction between the G3 and L5 proteins of the vaccinia virus entry-fusion complex.Smallpox vaccines: targets of protective immunity.The envelope G3L protein is essential for entry of vaccinia virus into host cellsVaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture.Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.Orthopoxvirus species and strain differences in cell entry.Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.A conserved sequence within the H2 subunit of the vaccinia virus entry/fusion complex is important for interaction with the A28 subunit and infectivity.Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene.Vaccinia virus entry/fusion complex subunit A28 is a target of neutralizing and protective antibodiesPrimary human leukocyte subsets differentially express vaccinia virus receptors enriched in lipid rafts.Characterization of a newly identified 35-amino-acid component of the vaccinia virus entry/fusion complex conserved in all chordopoxviruses.Poxvirus proteomics and virus-host protein interactions.Surf and turf: mechanism of enhanced virus spread during poxvirus infection.Antibody Recognition of Immunodominant Vaccinia Virus Envelope Proteins.Autographa californica multiple nucleopolyhedrovirus Ac92 (ORF92, P33) is required for budded virus production and multiply enveloped occlusion-derived virus formation.Vaccinia virus temperature-sensitive mutants in the A28 gene produce non-infectious virions that bind to cells but are defective in entry.Three conserved regions in baculovirus sulfhydryl oxidase, P33, are critical for enzymatic activity and function.Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange.The 2.1 Å structure of protein F9 and its comparison to L1, two components of the conserved poxvirus entry-fusion complex
P2860
Q24793662-5CFA335B-5350-4A47-89AC-BAAFDBE03B8BQ27002455-C28165AF-8A55-4613-8EB9-D1ABC620C700Q28477161-C2B75B50-2013-42CC-A422-8E6F19AB47E4Q30483178-B1D7473E-C44A-4CD0-99A4-CCA373AB84C1Q30978284-44BB7AD1-BC72-4859-8B76-980B76247DD9Q33718427-88CFC956-A08B-4FE1-B578-3B2895A802CBQ33724218-8D9DFCA8-3E6C-49A1-96D8-B0F62F0D7404Q33908798-B7BADD7D-8477-42F6-8FEA-F923901C2A05Q33930439-93CCA8E6-5BE2-4A5D-B89A-F71BD798E0C0Q34109783-E09FC000-70B8-484C-BFFC-CC80CB43847BQ34142767-91C356EE-61D6-4C61-9A65-83392E715424Q34202362-91B27984-0737-4CAC-B3C8-8700E1E1190FQ34233115-332CFEAA-8DC5-44B4-98E5-DCCF38CA3FF6Q34262005-66EC5D8D-3EB6-4CF4-9025-73AA5D45933EQ34434835-6DE7E12E-267F-47DD-A419-C35A0E0D831AQ34778139-F1753838-EA4C-4EF0-A890-337514CE7DB3Q34780607-2AD07D5E-AB05-4F7A-BA38-840B238FD4C1Q35024119-09ABB554-EB8E-4CEA-9E01-CED38E59DB8BQ35236032-8D4654CF-CF40-4C46-AD8F-ACCD57B32ABCQ35857238-629F628D-595A-4986-A8E2-31D20A823A48Q36315941-AFCD87D0-389C-452E-AEBB-3951D7D77069Q36673363-5FD07922-A103-4D0D-AAEB-EE8D29653263Q36747975-66A34E92-7BD3-40A8-982D-AB9326346D7EQ36954883-FF77EB8F-4EA1-4524-91E6-6284B59A1682Q37066691-B4CB66AF-8489-4064-ADCA-DF5A9838B8DEQ37123323-232823C3-86AE-44EF-B294-388F57684EADQ37452527-334C7757-671E-47B3-98C1-D6A43EED18E7Q37640977-7D5ECB80-EFEA-4DA7-A88B-415AF6E6AF34Q38632862-17276DFE-8C9B-4FBA-889C-1A8BE8BDA5BBQ39167579-FB02D80F-62A3-4B36-8072-801B317BE428Q39652753-808EBE1A-C9DF-4776-8BE9-0FC34B388FCFQ39696174-70314F1C-B4AD-435B-8050-3EC83B5AA587Q40042361-A9905AEF-7713-4E47-B4F0-2A2899EE429AQ40075760-C7F998FC-3DE7-45A9-9441-FE8AEF302200Q59127072-09EC3947-B705-4B51-80C4-BBF1417E92D0
P2860
Vaccinia virus A28L gene encodes an essential protein component of the virion membrane with intramolecular disulfide bonds formed by the viral cytoplasmic redox pathway.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Vaccinia virus A28L gene encod ...... ral cytoplasmic redox pathway.
@en
type
label
Vaccinia virus A28L gene encod ...... ral cytoplasmic redox pathway.
@en
prefLabel
Vaccinia virus A28L gene encod ...... ral cytoplasmic redox pathway.
@en
P2860
P1433
P1476
Vaccinia virus A28L gene encod ...... ral cytoplasmic redox pathway.
@en
P2093
Brian M Ward
Tatiana G Senkevich
P2860
P304
P356
10.1128/JVI.78.5.2348-2356.2004
P407
P50
P577
2004-03-01T00:00:00Z